Courses | Page 3 | AUA University - 世界杯英格兰vs伊朗波胆预测

Topic

Core Curriculum Related Education

Title	Category	Credit	Event date	Price
Bladder Cancer Treatment Dilemmas: The Cases You Face and What To Do about Them Webcast (2022)		2.00AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	Update recent AUA, European Association of Urology (EAU), and National Comprehensive Cancer Network (NCCN®) Guidelines® for the quickly evolving field of bladder cancer. Case scenarios will outline important changes as well as concepts essential in providing evidence-based care.ACKNOWLEDGEMENTSSupport provided by independent educational grants from:AstraZenecaBristol Myers SquibbMerck & Co., Inc.Pfizer, Inc.
Building a Primary Palliative Care Model for Urology Webcast (2021)		2.00AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	Building a Primary Palliative Care Model for Urology Webcast (2021) discusses aspects of palliative care that benefit patients, the urologist’s role and their collaboration with palliative care clinicians including:
Case-Based Discussion: BCR and Novel Pet Imaging & M0 CRPC Podcast (2021)		1.00AMA PRA Category 1 Credit™ 1.00 Non-Physician Participation		$0.00	fda批准用于晚期前列腺癌患者的多种治疗药物显著增加的直接结果是，临床医生面临着大量治疗选择和这些药物的潜在排序的挑战，从而使临床决策更加复杂。This activity will build upon the newly updated 2020 AUA Guidelines on Metastatic Hormone Sensitive Prostate Cancer (HSPC) and Castration-Resistant Prostate Cancer (CRPC).
Case-Based Discussion: Early M1 CRPC and Advanced M1 CRPC Podcast (2021)		1.00AMA PRA Category 1 Credit™ 1.00 Non-Physician Participation		$0.00	fda批准用于晚期前列腺癌患者的多种治疗药物显著增加的直接结果是，临床医生面临着大量治疗选择和这些药物的潜在排序的挑战，从而使临床决策更加复杂。This activity will build upon the newly updated 2020 AUA Guidelines on Metastatic Hormone Sensitive Prostate Cancer (HSPC) and Castration-Resistant Prostate Cancer (CRPC).
Case-Based Discussion: Role of Genetic Testing in Advanced M1 CRPC & M1 CRPC Post-Docetaxel, Neuroendocrine Cancer and End-of-Life Care Podcast (...		1.00AMA PRA Category 1 Credit™ 1.00 Non-Physician Participation		$0.00	fda批准用于晚期前列腺癌患者的多种治疗药物显著增加的直接结果是，临床医生面临着大量治疗选择和这些药物的潜在排序的挑战，从而使临床决策更加复杂。This activity will build upon the newly updated 2020 AUA Guidelines on Metastatic Hormone Sensitive Prostate Cancer (HSPC) and Castration-Resistant Prostate Cancer (CRPC).
Clinical Cases in Urology: Diagnosis and Treatment of Early Stage Testicular Cancer (2019)		2.00AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	成员只有好处!《泌尿外科指南》全面而严谨地总结了与各种疾病相关的证据，为泌尿外科教育提供了不可或缺的资源。《泌尿外科临床案例指南》以案例场景为基础，旨在帮助最大限度地发挥指南的影响。本病例将重点介绍AUA指南、早期睾丸癌的诊断和治疗。
Clinical Cases in Urology: Incontinence after Prostate Treatment (2019)		2.00AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	成员只有好处!《泌尿外科指南》全面而严谨地总结了与各种疾病相关的证据，为泌尿外科教育提供了不可或缺的资源。《泌尿外科临床案例指南》以案例场景为基础，旨在帮助最大限度地发挥指南的影响。本病例将重点讨论AUA/SUFU指南，前列腺治疗后尿失禁。
Clinical Cases in Urology: Recurrent Uncomplicated Urinary Tract Infections in Women (2019)		2.00AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	成员只有好处!《泌尿外科指南》全面而严谨地总结了与各种疾病相关的证据，为泌尿外科教育提供了不可或缺的资源。泌尿外科临床案例指南基于案例场景设计，以帮助最大限度地发挥指南的影响。本病例将重点关注AUA/CUA/SUFU指南《女性复发性无并发症尿路感染》。
Clinical Problem Solving (CPS) Protocol: Shared Decision Making and Engaging Disparities in Prostate Cancer Care (2021)		1.00AMA PRA Category 1 Credit™ 1.00 Non-Physician Participation		$0.00	Engaging Disparities in Prostate Cancer Care consists of multiple educational activities featuring a variety of formats for the urologic healthcare team to reinforce the essentials of SDM to better assist high-risk patients in regards to prostate cancer screening and treatment. A live webinar, Clinical Problem Solving (CPS) Protocol, and Podcast Series will enable participants to be better prepared to apply SDM in their practice.
Conflict of Interest Disclosures				$0.00	The mission of the AUA Office of Education is to provide quality, evidence-based continuing medical education that is independent and free of commercial bias to enhance the clinical competence and performance of urologists and the urologic care team.
Contemporary Pharmacotherapy for OAB 2022: Monotherapy and Combined Pharmacotherapy to Optimize Treatment Webcast (2022)		2.00AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	在过去的20年里，关于药物治疗膀胱过度活跃症(OAB)已经有了很多文章和争论。尽管如此，该领域仍在不断发展。OAB药物治疗仍然是一个积极研究和创新的领域。
Controversies, Confusion, and the Future of Urologic Post-Operative Opioid Prescribing Reduction Strategies (2022)		0.75AMA PRA Category 1 Credit™ 0.75 Non-Physician Participation		$0.00	This activity includes a multidisciplinary panel of experts discussing how urologists can reduce opioid prescribing, non-opioid multi-modal options, alternative therapies to pain management, managing opioid tolerant patients, and upcoming post-operative pain management opportunities.
Diagnosis and Management of Localized, Locally Advanced and Advanced Kidney Cancer Webcast (2022)		2.00AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	Kidney cancer is not a single disease; it is made up of several different types of cancer, each with a different histology, a different clinical course, responding differently to therapy and caused by different genes. After completing this course, attendees be able to describe the different types of kidney cancer and the genes that cause each. They will learn how to identify the different types of inherited versus sporadic forms of kidney cancer.
Difficult Cases in High-Risk Bladder Cancer: An Evidence-Based Approach Webcast (2022)		2.00AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	The course director will select 6 real cases from his own practice that represent challenging cases in bladder cancer and present them to his panelists. The panelists will review the available literature and formulate a treatment plan based upon the guidelines and published literature. The course director will then present the actual patient outcome and readdress the panelists with follow-up problems and questions to illustrate the many unique aspects of dealing with these patients.ACKNOWLEDGEMENTSSupport provided by independent educational grants from:
Diversity Equity and Inclusion in Urology: What Do We Need to Know Webcast (2022)		2.00AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	本课程将回顾泌尿学中未被充分代表的少数群体的统计数据，以及为什么多样性、公平和包容(DEI)倡议对于泌尿学的发展是必要的。我们将定义种族主义，并教育参与者不同形式的种族主义。我们将确定当前的策略，以增加泌尿科少数族裔的人数。

Pages